(S)-4-Ethyl-4-hydroxy-7,8-dihydro-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione, 95.0%, 500mg

(S)-3-((tert-Butoxycarbonyl)amino)-3-(naphthalen-2-yl)propanoic acid, 97%, 100mg

2-Chloro-N-(2-(2-chlorobenzoyl)-4-nitrophenyl)acetamide, 95.0%, 100g

Piperazine DL-Malate>98.0%(T)25g

2-Chloromethyl-5-(4-chlorophenyl)-1,3,4-thiadiazole, 95.0%, 1g

1-PHENYL-3-(PIPERIDIN-2-YLMETHYL)IMIDAZOLIDIN-2-ONE HYDROCHLORIDE, 95%, 100mg

4-((4-Boronophenyl)amino)-4-oxobutanoic acid, 98%, 5g

tert-Butyl (4-bromo-5-formylthiazol-2-yl)carbamate, 95.0%, 5g

TERT-BUTYL 7-(1-METHOXY-1-OXOPROPAN-2-YL)-3,4-DIHYDRO-1,8-NAPHTHYRIDINE-1(2H)-CARBOXYLATE, 95.0%, 1g

4-Borono-2-(trifluoromethyl)benzoic acid, 95.0%, 250mg

2,2-Dimethylmorpholine, 97.0%, 1g

4-(2-Hydroxyethyl)piperazine-1-(2-hydroxypropane-3-sulfonic Acid) [Good's buffer component for biological research]>98.0%(T)25g

(2R,4R)-tert-Butyl 4-amino-2-methylpyrrolidine-1-carboxylate, 95.0%, 250mg